Investor Information

Capital Increase 2017

4SC AG resolved to conduct a cash capital increase to raise funds to continue to advance its drug development programs for resminostat, 4SC-202 and 4SC-208.

Read more

The 4SC Share

General information on the share

Read more

Shareholder Structure

List of key investors

Read more

Financial Calendar

Financial schedule for 2017

Read more

Financial Reports

Download list of annual and quarterly reports

Read more

Key Figures

Multi-year overview

Read more

Conference Calls & Webcasts

Download list of conference calls and webcasts

Read more

Analyst Coverage

List of analysts compiling research on 4SC

Read more

Share this page:

Follow us on: